Impact of miR-181a on SIRT1 Expression and Senescence in Hutchinson–Gilford Progeria Syndrome
Diseases · 04.08.2025 · 13 (8) · 245
DOI: 10.3390/diseases13080245 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diseases, online erschienen am 04.08.2025. Verfasst von Eva-Maria Lederer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Epigenetics of Aging, Department of Dermatology and Allergy, TUM School of Medicine, Munich Institute of Biomedical Engineering (MIBE), Technical Uni…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG), Deutsche Forschungsgemeinschaft DFG.
Abstract (Originalsprache)
Background/Objectives: Hutchinson–Gilford progeria syndrome (HGPS) is a rare and fatal genetic disease caused by a silent mutation in the LMNA gene, leading to the production of progerin, a defective prelamin A variant. Progerin accumulation disrupts nuclear integrity, alters chromatin organization, and drives systemic cellular dysfunction. While autophagy and inflammation are key dysregulated pathways in HGPS, the role of microRNAs (miRNAs) in these processes remains poorly understood.
Methods
We performed an extensive literature review to identify miRNAs involved in autophagy and inflammation. Through stem-loop RT-qPCR in aging HGPS and control fibroblast strains, we identified significant miRNAs and focused on the most prominent one, miR-181a-5p, for in-depth analysis. We validated our in vitro findings with miRNA expression studies in skin biopsies from an HGPS mouse model and conducted functional assays in human fibroblasts, including immunofluorescence staining, β-Galactosidase assay, qPCR, and Western blot analysis. Transfection studies were performed using an miR-181a-5p mimic and its inhibitor.
Results
We identified miR-181a-5p as a critical regulator of premature senescence in HGPS. miR-181a-5p was significantly upregulated in HGPS fibroblasts and an HGPS mouse model, correlating with Sirtuin 1 (SIRT1) suppression and induction of senescence. Additionally, we demonstrated that TGFβ1 induced miR-181a-5p expression, linking inflammation to miRNA-mediated senescence. Inhibiting miR-181a-5p restored SIRT1 levels, increased proliferation, and alleviated senescence in HGPS fibroblasts, supporting its functional relevance in disease progression.
Conclusions
These findings highlight the important role of miR-181a-5p in premature aging and suggest its potential as a therapeutic target for modulating senescence in progeroid syndromes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Epigenetics of Aging, Department of Dermatology and Allergy, TUM School of Medicine, Munich Institute of Biomedical Engineering (MIBE), Technical University of Munich (TUM), 85748 Garching, Germany.
ORCID-Profile: Eva-Maria Lederer, Felix Quirin Fenzl, Moritz Schroll, Ramona Hartinger, Karima Djabali
Förderung
- Deutsche Forschungsgemeinschaft (DFG)
- Deutsche Forschungsgemeinschaft DFG
Zitieren
APA
Lederer, E. M., Fenzl, F. Q., Krüger, P., Schroll, M., Hartinger, R., & Djabali, K. (2025). Impact of miR-181a on SIRT1 Expression and Senescence in Hutchinson–Gilford Progeria Syndrome. Diseases, 13(8), 245. https://doi.org/10.3390/diseases13080245
Vancouver
Lederer EM, Fenzl FQ, Krüger P, Schroll M, Hartinger R, Djabali K. Impact of miR-181a on SIRT1 Expression and Senescence in Hutchinson–Gilford Progeria Syndrome. Diseases. 2025;13(8):245. doi:10.3390/diseases13080245
BibTeX
@article{Lederer2025,
author = {Lederer, Eva-Maria and Fenzl, Felix Quirin and Krüger, Peter and Schroll, Moritz and Hartinger, Ramona and Djabali, Karima},
title = {Impact of miR-181a on SIRT1 Expression and Senescence in Hutchinson–Gilford Progeria Syndrome},
journal = {Diseases},
year = {2025},
volume = {13},
number = {8},
pages = {245},
doi = {10.3390/diseases13080245}
}
EUVIMED